{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:24:09Z","timestamp":1758821049603,"version":"3.30.1"},"reference-count":109,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n<jats:title>:<\/jats:title>\n<jats:p>The biochemical integrity of the brain is critical in maintaining normal central\nnervous system (CNS) functions. One of the factors that plays an important role in\ncausing biochemical impairment of the brain is known as oxidative stress. Oxidative\nstress is generally defined as the excessive formation of free radicals relative to\nantioxidant defenses. The brain is particularly susceptible to oxidative stress because of\nits high oxygen consumption and lipid-rich content. Therefore, oxidative stress damage\nis associated with abnormal CNS function. Psychiatric disorders are debilitating\ndiseases. The underlying pathophysiology of psychiatric disorders is poorly defined and\nmay involve the interplay of numerous clinical factors and mechanistic mechanisms.\nConsiderable evidence suggests that oxidative stress plays a complex role in several\nneuropsychiatric disorders, including anxiety, bipolar disorder, depression, obsessivecompulsive\ndisorder, panic disorder, and schizophrenia. To address these issues, we\nreviewed the literature and considered the role of oxidative stress as one of the first\npathological changes in the course of neuropsychiatric disorders, which should receive\nmore attention in future research.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524023666230904150907","type":"journal-article","created":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T05:48:50Z","timestamp":1693979330000},"page":"1494-1505","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oxidative Stress is a New Avenue for Treatment of Neuropsychiatric Disorders: Hype of Hope?"],"prefix":"10.2174","volume":"24","author":[{"given":"Sajad Sahab","family":"Negah","sequence":"first","affiliation":[{"name":"Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of\nNeuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Forouzanfar","sequence":"additional","affiliation":[{"name":"Neuroscience Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of\nNeuroscience, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature09563","volume":"468","author":"van Os J.","year":"2010","unstructured":"van Os J.; Kenis G.; Rutten B.P.F.; The environment and schizophrenia. Nature  2010,468(7321),203-212","journal-title":"Nature"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","volume":"98","author":"Nanou E.","year":"2018","unstructured":"Nanou E.; Catterall W.A.; Calcium channels, synaptic plasticity, and neuropsychiatric disease. Neuron  2018,98(3),466-481","journal-title":"Neuron"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/nm.4225","volume":"22","author":"Mar\u00edn O.","year":"2016","unstructured":"Mar\u00edn O.; Developmental timing and critical windows for the treatment of psychiatric disorders. Nat Med  2016,22(11),1229-1238","journal-title":"Nat Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/092986707779941177","volume":"14","author":"Tsukahara H.","year":"2007","unstructured":"Tsukahara H.; Biomarkers for oxidative stress: Clinical application in pediatric medicine. Curr Med Chem  2007,14(3),339-351","journal-title":"Curr Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.smrv.2018.03.007","volume":"41","author":"Morris G.","year":"2018","unstructured":"Morris G.; Stubbs B.; K\u00f6hler C.A.; The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis. Sleep Med Rev  2018,41,255-265","journal-title":"Sleep Med Rev"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"6643950","DOI":"10.1155\/2021\/6643950","volume":"2021","author":"Azami S.","year":"2021","unstructured":"Azami S.; Shahriari Z.; Asgharzade S.; Farkhondeh T.; Sadeghi M.; Ahmadi F.; Therapeutic potential of saffron (Crocus sativus L.) in ischemia stroke. Evid Based Complement Alternat Med  2021,2021,6643950","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/B978-0-12-818553-7.00011-5","author":"Forouzanfar F.","year":"2020","unstructured":"Forouzanfar F.; Hosseinzadeh H.;  Protective Role of Nigella sativa and Thymoquinone in Oxidative Stress: A ReviewNuts and Seeds in Health and Disease Prevention  2020,127-146","journal-title":"Protective Role of Nigella sativa and Thymoquinone in Oxidative Stress: A ReviewNuts and Seeds in Health and Disease Prevention"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/1389203721666200214111816","volume":"21","author":"Ramani S.","year":"2020","unstructured":"Ramani S.; Pathak A.; Dalal V.; Paul A.; Biswas S.; Oxidative stress in autoimmune diseases: An under dealt malice. Curr Protein Pept Sci  2020,21(6),611-621","journal-title":"Curr Protein Pept Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.2174\/1568026614666141203143801","volume":"14","author":"Chiurchi\u00f9 V.","year":"2014","unstructured":"Chiurchi\u00f9 V.; Novel targets in multiple sclerosis: To oxidative stress and beyond. Curr Top Med Chem  2014,14(22),2590-2599","journal-title":"Curr Top Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbrc.2018.05.045","volume":"502","author":"Gutteridge J.M.C.","year":"2018","unstructured":"Gutteridge J.M.C.; Halliwell B.; Mini-Review: Oxidative stress, redox stress or redox success? Biochem Biophys Res Commun  2018,502(2),183-186","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"Dias V.","year":"2013","unstructured":"Dias V.; Junn E.; Mouradian M.M.; The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis  2013,3(4),461-491","journal-title":"J Parkinsons Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.neulet.2009.11.033","volume":"469","author":"Padurariu M.","year":"2010","unstructured":"Padurariu M.; Ciobica A.; Hritcu L.; Stoica B.; Bild W.; Stefanescu C.; Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett  2010,469(1),6-10","journal-title":"Neurosci Lett"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"Valko M.","year":"2007","unstructured":"Valko M.; Leibfritz D.; Moncol J.; Cronin M.T.D.; Mazur M.; Telser J.; Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol  2007,39(1),44-84","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/oxim.1.1.6843","volume":"1","author":"Aitken R.J.","year":"2008","unstructured":"Aitken R.J.; Roman S.D.; Antioxidant systems and oxidative stress in the testes. Oxid Med Cell Longev  2008,1(1),15-24","journal-title":"Oxid Med Cell Longev"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"Liguori I.","year":"2018","unstructured":"Liguori I.; Russo G.; Curcio F.; Oxidative stress, aging, and diseases. Clin Interv Aging  2018,13,757-772","journal-title":"Clin Interv Aging"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","volume":"24","author":"Kim G.H.","year":"2015","unstructured":"Kim G.H.; Kim J.E.; Rhie S.J.; Yoon S.; The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol  2015,24(4),325-340","journal-title":"Exp Neurobiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3390\/nu4101399","volume":"4","author":"Johnson W.M.","year":"2012","unstructured":"Johnson W.M.; Wilson-Delfosse A.L.; Mieyal J.J.; Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients  2012,4(10),1399-1440","journal-title":"Nutrients"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.pnpbp.2017.02.017","volume":"76","author":"van Velzen L.S.","year":"2017","unstructured":"van Velzen L.S.; Wijdeveld M.; Black C.N.; Oxidative stress and brain morphology in individuals with depression, anxiety and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry  2017,76,140-144","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000063573","volume":"46","author":"Kuloglu M.","year":"2002","unstructured":"Kuloglu M.; Atmaca M.; Tezcan E.; Ge\u00e7ici \u00d6.; Tunckol H.; Ustundag B.; Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology  2002,46(1),27-32","journal-title":"Neuropsychobiology"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.tips.2010.12.002","volume":"32","author":"Halliwell B.","year":"2011","unstructured":"Halliwell B.; Free radicals and antioxidants \u2013 quo vadis? Trends Pharmacol Sci  2011,32(3),125-130","journal-title":"Trends Pharmacol Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2217\/17460875.2.4.403","volume":"2","author":"Adibhatla R.M.","year":"2007","unstructured":"Adibhatla R.M.; Hatcher J.F.; Role of lipids in brain injury and diseases. Future Lipidol  2007,2(4),403-422","journal-title":"Future Lipidol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"7909380","DOI":"10.1155\/2016\/7909380","volume":"2016","author":"Chiurchi\u00f9 V.","year":"2016","unstructured":"Chiurchi\u00f9 V.; Orlacchio A.; Maccarrone M.; Is modulation of oxidative stress an answer? The state of the art of redox therapeutic actions in neurodegenerative diseases. Oxid Med Cell Longev  2016,2016,7909380","journal-title":"Oxid Med Cell Longev"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1089\/ars.2010.3547","volume":"15","author":"Chiurchi\u00f9 V.","year":"2011","unstructured":"Chiurchi\u00f9 V.; Maccarrone M.; Chronic inflammatory disorders and their redox control: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal  2011,15(9),2605-2641","journal-title":"Antioxid Redox Signal"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2174\/156652406779010786","volume":"6","author":"Lehtinen M.","year":"2006","unstructured":"Lehtinen M.; Bonni A.; Modeling oxidative stress in the central nervous system. Curr Mol Med  2006,6(8),871-881","journal-title":"Curr Mol Med"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1089\/ars.2010.3208","volume":"14","author":"Massaad C.A.","year":"2011","unstructured":"Massaad C.A.; Klann E.; Reactive oxygen species in the regulation of synaptic plasticity and memory. Antioxid Redox Signal  2011,14(10),2013-2054","journal-title":"Antioxid Redox Signal"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"Maes M.","year":"2009","unstructured":"Maes M.; Yirmyia R.; Noraberg J.; The inflammatory and neurodegenerative (IandND) hypothesis of depression: Leads for future research and new drug developments in depression. Metab Brain Dis  2009,24(1),27-53","journal-title":"Metab Brain Dis"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/07853890801923753","volume":"40","author":"Shao L.","year":"2008","unstructured":"Shao L.; Martin M.V.; Watson S.J.; Mitochondrial involvement in psychiatric disorders. Ann Med  2008,40(4),281-295","journal-title":"Ann Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/CIRCRESAHA.118.313764","volume":"124","author":"Greaney J.L.","year":"2019","unstructured":"Greaney J.L.; Saunders E.F.H.; Santhanam L.; Alexander L.M.; Oxidative stress contributes to microvascular endothelial dysfunction in men and women with major depressive disorder. Circ Res  2019,124(4),564-574","journal-title":"Circ Res"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-10-4711-4_2","author":"Dalal V.","year":"2017","unstructured":"Dalal V.; Sharma N.K.; Biswas S.;  Oxidative stress: Diagnostic methods and application in medical science  2017","journal-title":"Oxidative stress: Diagnostic methods and application in medical science"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11920-019-1002-7","volume":"21","author":"Meier S.M.","year":"2019","unstructured":"Meier S.M.; Deckert J.; Genetics of anxiety disorders. Curr Psychiatry Rep  2019,21(3),16","journal-title":"Curr Psychiatry Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1754073911430251","volume":"4","author":"Blair K.S.","year":"2012","unstructured":"Blair K.S.; Blair R.J.R.; A cognitive neuroscience approach to generalized anxiety disorder and social phobia. Emot Rev  2012,4(2),133-138","journal-title":"Emot Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.9758\/cpn.2019.17.1.12","volume":"17","author":"Yoon H.J.","year":"2019","unstructured":"Yoon H.J.; Seo E.H.; Kim J.J.; Choo I.L.H.; Neural correlates of self-referential processing and their clinical implications in social anxiety disorder. Clin Psychopharmacol Neurosci  2019,17(1),12-24","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1875-5364(14)60089-3","volume":"12","author":"Kumar A.","year":"2014","unstructured":"Kumar A.; Kaur G.; Rinwa P.; Buspirone along with melatonin attenuates oxidative damage and anxiety-like behavior in a mouse model of immobilization stress. Chin J Nat Med  2014,12(8),582-589","journal-title":"Chin J Nat Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"e74522","DOI":"10.1371\/journal.pone.0074522","volume":"8","author":"Patki G.","year":"2013","unstructured":"Patki G.; Allam F.H.; Atrooz F.; Grape powder intake prevents ovariectomy-induced anxiety-like behavior, memory impairment and high blood pressure in female Wistar rats. PLoS One  2013,8(9),e74522","journal-title":"PLoS One"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/j.neuropharm.2011.10.006","volume":"62","author":"Brocardo P.S.","year":"2012","unstructured":"Brocardo P.S.; Boehme F.; Patten A.; Cox A.; Gil-Mohapel J.; Christie B.R.; Anxiety- and depression-like behaviors are accompanied by an increase in oxidative stress in a rat model of fetal alcohol spectrum disorders: Protective effects of voluntary physical exercise. Neuropharmacology  2012,62(4),1607-1618","journal-title":"Neuropharmacology"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.exger.2006.05.018","volume":"42","author":"Berry A.","year":"2007","unstructured":"Berry A.; Capone F.; Giorgio M.; Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice. Exp Gerontol  2007,42(1-2),37-45","journal-title":"Exp Gerontol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1749-6632.2001.tb05632.x","volume":"928","author":"Stadtman E.R.","year":"2001","unstructured":"Stadtman E.R.; Protein oxidation in aging and age-related diseases. Ann N Y Acad Sci  2001,928(1),22-38","journal-title":"Ann N Y Acad Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0197-4580(02)00019-2","volume":"23","author":"Floyd R.","year":"2002","unstructured":"Floyd R.; Hensley K.; Oxidative stress in brain agingImplications for therapeutics of neurodegenerative diseases. Neurobiol Aging  2002,23(5),795-807","journal-title":"Neurobiol Aging"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1124\/jpet.108.137208","volume":"326","author":"Masood A.","year":"2008","unstructured":"Masood A.; Nadeem A.; Mustafa S.J.; O\u2019Donnell J.M.; Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J Pharmacol Exp Ther  2008,326(2),369-379","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jad.2017.04.042","volume":"219","author":"Steenkamp L.R.","year":"2017","unstructured":"Steenkamp L.R.; Hough C.M.; Reus V.I.; Severity of anxiety\u2013 but not depression\u2013 is associated with oxidative stress in Major Depressive Disorder. J Affect Disord  2017,219,193-200","journal-title":"J Affect Disord"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1017\/S0033291716002828","volume":"47","author":"Black C.N.","year":"2017","unstructured":"Black C.N.; Bot M.; Scheffer P.G.; Penninx B.W.J.H.; Oxidative stress in major depressive and anxiety disorders, and the association with antidepressant use; results from a large adult cohort. Psychol Med  2017,47(5),936-948","journal-title":"Psychol Med"},{"key":"ref=42","first-page":"415","volume":"4","author":"Belmaker R.H.","year":"2004","unstructured":"Belmaker R.H.; Bersudsky Y.; Bipolar disorder: Treatment. Discov Med  2004,4(24),415-420","journal-title":"Discov Med"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","volume":"68","author":"Angst F.","year":"2002","unstructured":"Angst F.; Stassen H.H.; Clayton P.J.; Angst J.; Mortality of patients with mood disorders: Follow-up over 34\u201338 years. J Affect Disord  2002,68(2-3),167-181","journal-title":"J Affect Disord"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0165-1781(03)00220-8","volume":"121","author":"Ranjekar P.K.","year":"2003","unstructured":"Ranjekar P.K.; Hinge A.; Hegde M.V.; Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res  2003,121(2),109-122","journal-title":"Psychiatry Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.psychres.2006.03.025","volume":"153","author":"Andreazza A.C.","year":"2007","unstructured":"Andreazza A.C.; Noronha Frey B.; Erdtmann B.; DNA damage in bipolar disorder. Psychiatry Res  2007,153(1),27-32","journal-title":"Psychiatry Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s11064-010-0195-2","volume":"35","author":"Steckert A.V.","year":"2010","unstructured":"Steckert A.V.; Valvassori S.S.; Moretti M.; Dal-Pizzol F.; Quevedo J.; Role of oxidative stress in the pathophysiology of bipolar disorder. Neurochem Res  2010,35(9),1295-1301","journal-title":"Neurochem Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijdevneu.2010.08.007","volume":"29","author":"Clay H.B.","year":"2011","unstructured":"Clay H.B.; Sillivan S.; Konradi C.; Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci  2011,29(3),311-324","journal-title":"Int J Dev Neurosci"},{"key":"ref=48","first-page":"516","volume":"33","author":"Andreazza A.C.","year":"2008","unstructured":"Andreazza A.C.; Kauer-Sant\u2019Anna M.; Frey B.N.; Effects of mood stabilizers on DNA damage in an animal model of mania. J Psychiatry Neurosci  2008,33(6),516-524","journal-title":"J Psychiatry Neurosci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1399-5618.2006.00318.x","volume":"8","author":"Frey B.N.","year":"2006","unstructured":"Frey B.N.; Martins M.R.; Petronilho F.C.; Dal-Pizzol F.; Quevedo J.; Kapczinski F.; Increased oxidative stress after repeated amphetamine exposure: Possible relevance as a model of mania. Bipolar Disord  2006,8(3),275-280","journal-title":"Bipolar Disord"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1017\/S1461145711001416","volume":"15","author":"Tan H.","year":"2012","unstructured":"Tan H.; Young L.T.; Shao L.; Che Y.; Honer W.G.; Wang J.F.; Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int J Neuropsychopharmacol  2012,15(9),1275-1285","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/cbf.940","volume":"20","author":"Kuloglu M.","year":"2002","unstructured":"Kuloglu M.; Ustundag B.; Atmaca M.; Canatan H.; Tezcan A.E.; Cinkilinc N.; Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct  2002,20(2),171-175","journal-title":"Cell Biochem Funct"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1399-5618.2009.00717.x","volume":"11","author":"Wang J.F.","year":"2009","unstructured":"Wang J.F.; Shao L.; Sun X.; Young L.T.; Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord  2009,11(5),523-529","journal-title":"Bipolar Disord"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2008.04.013","volume":"111","author":"Andreazza A.C.","year":"2008","unstructured":"Andreazza A.C.; Kauer-Sant\u2019Anna M.; Frey B.N.; Oxidative stress markers in bipolar disorder: A meta-analysis. J Affect Disord  2008,111(2-3),135-144","journal-title":"J Affect Disord"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.psychres.2014.04.005","volume":"218","author":"Brown N.C.","year":"2014","unstructured":"Brown N.C.; Andreazza A.C.; Young L.T.; An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res  2014,218(1-2),61-68","journal-title":"Psychiatry Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.pnpbp.2006.06.011","volume":"31","author":"Frey B.N.","year":"2007","unstructured":"Frey B.N.; Andreazza A.C.; Kunz M.; Increased oxidative stress and DNA damage in bipolar disorder: A twin-case report. Prog Neuropsychopharmacol Biol Psychiatry  2007,31(1),283-285","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jagp.2014.05.008","volume":"23","author":"Andreazza A.C.","year":"2015","unstructured":"Andreazza A.C.; Gildengers A.; Rajji T.K.; Zuzarte P.M.L.; Mulsant B.H.; Young L.T.; Oxidative stress in older patients with bipolar disorder. Am J Geriatr Psychiatry  2015,23(3),314-319","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.psychres.2018.03.089","volume":"264","author":"Valvassori S.S.","year":"2018","unstructured":"Valvassori S.S.; Bavaresco D.V.; Feier G.; Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes. Psychiatry Res  2018,264,192-201","journal-title":"Psychiatry Res"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"514","DOI":"10.30773\/pi.2016.12.31","volume":"15","author":"Akarsu S.","year":"2018","unstructured":"Akarsu S.; Bolu A.; Aydemir E.; The relationship between the number of manic episodes and oxidative stress indicators in bipolar disorder. Psychiatry Investig  2018,15(5),514-519","journal-title":"Psychiatry Investig"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.psyneuen.2014.09.025","volume":"51","author":"Black C.N.","year":"2015","unstructured":"Black C.N.; Bot M.; Scheffer P.G.; Cuijpers P.; Penninx B.W.J.H.; Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology  2015,51,164-175","journal-title":"Psychoneuroendocrinology"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","volume":"35","author":"Maes M.","year":"2011","unstructured":"Maes M.; Galecki P.; Chang Y.S.; Berk M.; A review on the oxidative and nitrosative stress (OandNS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry  2011,35(3),676-692","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11064-006-9258-9","volume":"32","author":"Eren \u0130.","year":"2007","unstructured":"Eren \u0130.; Naz\u0131ro\u011flu M.; Demirda\u015f A.; Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat. Neurochem Res  2007,32(3),497-505","journal-title":"Neurochem Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ejps.2015.10.010","volume":"81","author":"Todorovi\u0107 N.","year":"2016","unstructured":"Todorovi\u0107 N.; Tomanovi\u0107 N.; Gass P.; Filipovi\u0107 D.; Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats. Eur J Pharm Sci  2016,81,94-102","journal-title":"Eur J Pharm Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pbb.2006.09.008","volume":"85","author":"Desouza F.","year":"2006","unstructured":"Desouza F.; Rodrigues M.; Tufik S.; Nobrega J.; Dalmeida V.; Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats. Pharmacol Biochem Behav  2006,85(2),400-407","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jep.2009.02.029","volume":"123","author":"Zhang D.","year":"2009","unstructured":"Zhang D.; Wen X.; Wang X.; Shi M.; Zhao Y.; Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress. J Ethnopharmacol  2009,123(1),55-60","journal-title":"J Ethnopharmacol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.0924-2708.2004.00090.x","volume":"16","author":"Yanik M.","year":"2004","unstructured":"Yanik M.; Erel O.; Kati M.; The relationship between potency of oxidative stress and severity of depression. Acta Neuropsychiatr  2004,16(4),200-203","journal-title":"Acta Neuropsychiatr"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PSY.0000000000000009","volume":"76","author":"Palta P.","year":"2014","unstructured":"Palta P.; Samuel L.J.; Miller E.R.; Szanton S.L.; Depression and oxidative stress: Results from a meta-analysis of observational studies. Psychosom Med  2014,76(1),12-19","journal-title":"Psychosom Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e0138904","DOI":"10.1371\/journal.pone.0138904","volume":"10","author":"Liu T.","year":"2015","unstructured":"Liu T.; Zhong S.; Liao X.; A meta-analysis of oxidative stress markers in depression. PLoS One  2015,10(10),e0138904","journal-title":"PLoS One"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jpsychires.2018.02.023","volume":"102","author":"Diniz B.S.","year":"2018","unstructured":"Diniz B.S.; Mendes-Silva A.P.; Silva L.B.; Oxidative stress markers imbalance in late-life depression. J Psychiatr Res  2018,102,29-33","journal-title":"J Psychiatr Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00406-017-0812-z","volume":"268","author":"Pasquali M.A.","year":"2018","unstructured":"Pasquali M.A.; Harlow B.L.; Soares C.N.; A longitudinal study of neurotrophic, oxidative, and inflammatory markers in first-onset depression in midlife women. Eur Arch Psychiatry Clin Neurosci  2018,268(8),771-781","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3390\/antiox10081256","volume":"10","author":"Katren\u010d\u00edkov\u00e1 B.","year":"2021","unstructured":"Katren\u010d\u00edkov\u00e1 B.; Vav\u00e1kov\u00e1 M.; Paduchov\u00e1 Z.; Oxidative stress markers and antioxidant enzymes in children and adolescents with depressive disorder and impact of omega-3 fatty acids in randomised clinical trial. Antioxidants  2021,10(8),1256","journal-title":"Antioxidants"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"8","DOI":"10.2174\/1570163816666191011105050","volume":"18","author":"Talaei A.","year":"2021","unstructured":"Talaei A.; Forouzanfar F.; Akhondzadeh S.; Medicinal plants in the treatment of obsessive-compulsive disorder: A review. Curr Drug Discov Technol  2021,18(1),8-16","journal-title":"Curr Drug Discov Technol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1139\/cjpp-2019-0381","volume":"98","author":"Talaei A.","year":"2020","unstructured":"Talaei A.; Hosseini F.F.; Aghili Z.; A comparative, single-blind, randomized study on quetiapine and aripiperazole augmentation in treatment of selective serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Can J Physiol Pharmacol  2020,98(4),236-242","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jpsychires.2013.08.010","volume":"47","author":"Kandemir H.","year":"2013","unstructured":"Kandemir H.; Abuhandan M.; Aksoy N.; Savik E.; Kaya C.; Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder. J Psychiatr Res  2013,47(11),1831-1834","journal-title":"J Psychiatr Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/pcn.12362","volume":"70","author":"Alici D.","year":"2016","unstructured":"Alici D.; Bulbul F.; Virit O.; Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci  2016,70(2),109-115","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.pnpbp.2007.10.002","volume":"32","author":"Selek S.","year":"2008","unstructured":"Selek S.; Herken H.; Bulut M.; Oxidative imbalance in obsessive compulsive disorder patients: A total evaluation of oxidant\u2013antioxidant status. Prog Neuropsychopharmacol Biol Psychiatry  2008,32(2),487-491","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12291-009-0035-9","volume":"24","author":"Chakraborty S.","year":"2009","unstructured":"Chakraborty S.; Dasgupta A.; Das H.N.; Singh O.P.; Mandal A.K.; Mandal N.; Study of oxidative stress in obsessive compulsive disorder in response to treatment with Fluoxetine. Indian J Clin Biochem  2009,24(2),194-197","journal-title":"Indian J Clin Biochem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.pnpbp.2009.01.001","volume":"33","author":"Chakraborty S.","year":"2009","unstructured":"Chakraborty S.; Singh O.P.; Dasgupta A.; Mandal N.; Das H.N.; Correlation between lipid peroxidation-induced TBARS level and disease severity in obsessive\u2013compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry  2009,33(2),363-366","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1440-1819.2005.01426.x","volume":"59","author":"Atmaca M.","year":"2005","unstructured":"Atmaca M.; Tezcan E.; Kuloglu M.; Ustundag B.; Plasma nitrate values in patients with obsessive-compulsive disorder. Psychiatry Clin Neurosci  2005,59(5),621-623","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.pnpbp.2008.10.004","volume":"33","author":"Ozdemir E.","year":"2009","unstructured":"Ozdemir E.; Cetinkaya S.; Ersan S.; Kucukosman S.; Ersan E.E.; Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive\u2013compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry  2009,33(1),62-65","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1590\/1516-4446-2021-1740","volume":"44","author":"Dan\u0131\u015fman Sonkurt M.","year":"2022","unstructured":"Dan\u0131\u015fman Sonkurt M.; Alt\u0131n\u00f6z A.E.; K\u00f6\u015fger F.; Yi\u011fitaslan S.; G\u00fcle\u00e7 G.; E\u015fsizo\u011flu A.; Are there differences in oxidative stress and inflammatory processes between the autogenous and reactive subtypes of obsessive-compulsive disorder? A controlled cross-sectional study. Br J Psychiatry  2022,44(2),171-177","journal-title":"Br J Psychiatry"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5152\/pcp.2022.21318","volume":"32","author":"Kurhan F.","year":"2022","unstructured":"Kurhan F.; Kam\u0131\u015f G.Z.; Alp H.H.; Akyuz Cim E.F.; Atli A.; A Cross-Sectional Measurement of Endogenous Oxidative Stress Marker Levels in Obsessive Compulsive Disorder. Psychiatry Clin Psychopharmacol  2022,32(3),215-221","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.hlc.2017.01.001","volume":"26","author":"Greenslade J.H.","year":"2017","unstructured":"Greenslade J.H.; Hawkins T.; Parsonage W.; Cullen L.; Panic disorder in patients presenting to the emergency department with chest pain: Prevalence and presenting symptoms. Heart Lung Circ  2017,26(12),1310-1316","journal-title":"Heart Lung Circ"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/npp.2014.92","volume":"39","author":"Hodges L.M.","year":"2014","unstructured":"Hodges L.M.; Fyer A.J.; Weissman M.M.; Logue M.W.; Haghighi F.; Evgrafov O.; Evidence for linkage and association of GABRB3 and GABRA5 to panic disorder. Neuropsychopharmacology  2014,39(10),2423-2431","journal-title":"Neuropsychopharmacology"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000067810","volume":"46","author":"Kuloglu M.","year":"2002","unstructured":"Kuloglu M.; Atmaca M.; Tezcan E.; Ustundag B.; Bulut S.; Antioxidant enzyme and malondialdehyde levels in patients with panic disorder. Neuropsychobiology  2002,46(4),186-189","journal-title":"Neuropsychobiology"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/00207450701769026","volume":"118","author":"Ersoy M.A.","year":"2008","unstructured":"Ersoy M.A.; Selek S.; Celik H.; Role of oxidative and antioxidative parameters in etiopathogenesis and prognosis of panic disorder. Int J Neurosci  2008,118(7),1025-1037","journal-title":"Int J Neurosci"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4306\/pi.2013.10.4.317","volume":"10","author":"Gul I.G.","year":"2013","unstructured":"Gul I.G.; Karlidag R.; Cumurcu B.E.; The effect of agoraphobia on oxidative stress in panic disorder. Psychiatry Investig  2013,10(4),317-325","journal-title":"Psychiatry Investig"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hup.742","volume":"21","author":"Herken H.","year":"2006","unstructured":"Herken H.; Akyol O.; Yilmaz H.R.; Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: Alterations by antidepressant treatment. Hum Psychopharmacol  2006,21(1),53-59","journal-title":"Hum Psychopharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1055\/s-0033-1343494","volume":"63","author":"Nahar Z.","year":"2013","unstructured":"Nahar Z.; Sarwar M.; Safiqul Islam M.; Determination of serum antioxidant vitamins, glutathione and MDA levels in panic disorder patients. Drug Res (Stuttg)  2013,63(8),424-428","journal-title":"Drug Res (Stuttg)"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3389\/fpsyt.2019.00892","volume":"10","author":"Momtazmanesh S.","year":"2019","unstructured":"Momtazmanesh S.; Zare-Shahabadi A.; Rezaei N.; Cytokine alterations in schizophrenia: An updated review. Front Psychiatry  2019,10,892","journal-title":"Front Psychiatry"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41398-021-01607-0","volume":"11","author":"Murphy C.E.","year":"2021","unstructured":"Murphy C.E.; Walker A.K.; Weickert C.S.; Neuroinflammation in schizophrenia: The role of nuclear factor kappa B. Transl Psychiatry  2021,11(1),528","journal-title":"Transl Psychiatry"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.neubiorev.2010.10.008","volume":"35","author":"Bitanihirwe B.K.Y.","year":"2011","unstructured":"Bitanihirwe B.K.Y.; Woo T.U.W.; Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev  2011,35(3),878-893","journal-title":"Neurosci Biobehav Rev"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/tp.2017.4","volume":"7","author":"van Kesteren C F MG.","year":"2017","unstructured":"van Kesteren C F MG.; Gremmels H.; de Witte L.D.; Immune involvement in the pathogenesis of schizophrenia: A meta-analysis on postmortem brain studies. Transl Psychiatry  2017,7(3),e1075","journal-title":"Transl Psychiatry"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/sj.mp.4000789","volume":"6","author":"Herken H.","year":"2001","unstructured":"Herken H.; Uz E.; \u00d6zyurt H.; S\u00f6\u011f\u00fct S.; Virit O.; Akyol \u00d6.; Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia. Mol Psychiatry  2001,6(1),66-73","journal-title":"Mol Psychiatry"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145710000805","volume":"14","author":"Gawryluk J.W.","year":"2011","unstructured":"Gawryluk J.W.; Wang J.F.; Andreazza A.C.; Shao L.; Young L.T.; Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol  2011,14(1),123-130","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1155\/2006\/248387","volume":"22","author":"Yao J.K.","year":"2006","unstructured":"Yao J.K.; Leonard S.; Reddy R.; Altered glutathione redox state in schizophrenia. Dis Markers  2006,22(1-2),83-93","journal-title":"Dis Markers"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/00004714-200304000-00004","volume":"23","author":"Zhang X.Y.","year":"2003","unstructured":"Zhang X.Y.; Zhou D.F.; Cao L.Y.; Zhang P.Y.; Wu G.Y.; Shen Y.C.; The effect of risperidone treatment on superoxide dismutase in schizophrenia. J Clin Psychopharmacol  2003,23(2),128-131","journal-title":"J Clin Psychopharmacol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.pnpbp.2009.06.018","volume":"33","author":"Raffa M.","year":"2009","unstructured":"Raffa M.; Mechri A.; Othman L.B.; Fendri C.; Gaha L.; Kerkeni A.; Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry  2009,33(7),1178-1183","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12031-018-1165-4","volume":"66","author":"Bai Z.L.","year":"2018","unstructured":"Bai Z.L.; Li X.S.; Chen G.Y.; Serum oxidative stress marker levels in unmedicated and medicated patients with schizophrenia. J Mol Neurosci  2018,66(3),428-436","journal-title":"J Mol Neurosci"},{"key":"ref=99","author":"Fraguas D.","year":"2018","unstructured":"Fraguas D.; D\u00edaz-Caneja C.M.; Ayora M.; Hern\u00e1ndez-\u00c1lvarez F.; Rodr\u00edguez-Quiroga A.; Recio S.; Oxidative stress and inflammation in first-episode psychosis: A systematic review and meta-analysis. Schizophr Bull  2018","journal-title":"Schizophr Bull"},{"key":"ref=100","first-page":"9","volume":"99","author":"Wang Y.P.","year":"2019","unstructured":"Wang Y.P.; Zhang P.F.; Yuan X.X.; Effects of oxidative stress on cognitive impairment in first episode schizophrenia. Zhonghua Yi Xue Za Zhi  2019,99(1),9-13","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.04-2400fje","volume":"19","author":"Desrumaux C.","year":"2005","unstructured":"Desrumaux C.; Risold P.Y.; Schroeder H.; Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice. FASEB J  2005,19(2),1-16","journal-title":"FASEB J"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.lfs.2007.05.001","volume":"81","author":"Souza C.G.","year":"2007","unstructured":"Souza C.G.; Moreira J.D.; Siqueira I.R.; Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci  2007,81(3),198-203","journal-title":"Life Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.brainres.2006.04.076","volume":"1097","author":"Frey B.N.","year":"2006","unstructured":"Frey B.N.; Valvassori S.S.; Gomes K.M.; Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure. Brain Res  2006,1097(1),224-229","journal-title":"Brain Res"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/hup.829","volume":"22","author":"Sarandol A.","year":"2007","unstructured":"Sarandol A.; Sarandol E.; Eker S.S.; Erdinc S.; Vatansever E.; Kirli S.; Major depressive disorder is accompanied with oxidative stress: Short-term antidepressant treatment does not alter oxidative\u2013antioxidative systems. Hum Psychopharmacol  2007,22(2),67-73","journal-title":"Hum Psychopharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0165-0327(00)00199-3","volume":"64","author":"Bilici M.","year":"2001","unstructured":"Bilici M.; Efe H.; K\u00f6ro\u011flu M.A.; Uydu H.A.; Bekaro\u011flu M.; De\u011fer O.; Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments. J Affect Disord  2001,64(1),43-51","journal-title":"J Affect Disord"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0327(01)00421-9","volume":"72","author":"Srivastava N.","year":"2002","unstructured":"Srivastava N.; Barthwal M.K.; Dalal P.K.; A study on nitric oxide, \u03b2-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord  2002,72(1),45-52","journal-title":"J Affect Disord"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","volume":"38","author":"Herken H.","year":"2007","unstructured":"Herken H.; Gurel A.; Selek S.; Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: Impact of antidepressant treatment. Arch Med Res  2007,38(2),247-252","journal-title":"Arch Med Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","volume":"62","author":"Reddy R.","year":"2003","unstructured":"Reddy R.; Keshavan M.; Yao J.K.; Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res  2003,62(3),205-212","journal-title":"Schizophr Res"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","volume":"81","author":"Zhang X.Y.","year":"2006","unstructured":"Zhang X.Y.; Tan Y.L.; Cao L.Y.; Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr Res  2006,81(2-3),291-300","journal-title":"Schizophr Res"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230904150907","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220695\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230904150907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,7]],"date-time":"2024-12-07T06:45:52Z","timestamp":1733553952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220695\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":109,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524023666230904150907","relation":{},"ISSN":["1566-5240"],"issn-type":[{"type":"print","value":"1566-5240"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-11","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}